Co-morbidity, ageing and predicted mortality in antiretroviral treated Australian men: a quantitative analysis

scientific article

Co-morbidity, ageing and predicted mortality in antiretroviral treated Australian men: a quantitative analysis is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2013PLoSO...878403F
P356DOI10.1371/JOURNAL.PONE.0078403
P932PMC publication ID3808383
P698PubMed publication ID24205222
P5875ResearchGate publication ID258351289

P2093author name stringLuis Furuya-Kanamori
Mark D Kelly
Samantha J McKenzie
P2860cites workPremature age-related comorbidities among HIV-infected persons compared with the general population.Q51000618
Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.Q53608173
A Coefficient of Agreement for Nominal ScalesQ57167717
Health behaviors of smokers, ex-smokers, and never smokers in an HMOQ74153195
Risk factors and causes of death in the Australian HIV Observational DatabaseQ79789480
HIV and ageing: premature ageing or premature conclusions?Q83063604
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studiesQ24597052
A new look at the statistical model identificationQ26778401
HIV infection and the risk of acute myocardial infarctionQ27347231
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study InvestigatorsQ29547281
Heart disease and stroke statistics--2012 update: a report from the American Heart AssociationQ29547909
Long-term survival in HIV positive patients with up to 15 Years of antiretroviral therapyQ31106702
Mortality by causes in HIV-infected adults: comparison with the general population.Q33898621
Microalbuminuria is associated with all-cause and AIDS mortality in women with HIV infectionQ33925114
Veterans Aging Cohort Study (VACS): Overview and descriptionQ34629666
Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*).Q34762935
Age at Cancer Diagnosis Among Persons With AIDS in the United StatesQ34766695
Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkersQ34802684
An internationally generalizable risk index for mortality after one year of antiretroviral therapy.Q34813110
Independent effects of HIV, aging, and HAART on brain volumetric measures.Q35827867
HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working GroupQ36147395
Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine careQ36492436
Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysisQ36747893
Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity?Q36942966
HIV medications: an update and review of metabolic complicationsQ37981602
Lifetime drinking trajectories among veterans in treatment for HIV.Q39459779
Premature and accelerated aging: HIV or HAART?Q39474417
Screening and management of renal disease in human immunodeficiency virus-infected patients in AustraliaQ43968568
Tenofovir-associated proteinuriaQ44004397
Adherence to HIV treatment guidelines for comorbid disease assessment and initiation of antiretroviral therapyQ44933865
Inhibition of telomerase activity by human immunodeficiency virus (HIV) nucleos(t)ide reverse transcriptase inhibitors: a potential factor contributing to HIV-associated accelerated agingQ45353122
The influence of sex, race/ethnicity, and educational attainment on human immunodeficiency virus death rates among adults, 1993-2007.Q45354439
Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy.Q46077395
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectanti-retroviral agentQ50430310
P304page(s)e78403
P577publication date2013-10-25
P1433published inPLOS OneQ564954
P1476titleCo-morbidity, ageing and predicted mortality in antiretroviral treated Australian men: a quantitative analysis
P478volume8

Reverse relations

cites work (P2860)
Q35193790A pilot feasibility and acceptability study of yoga/meditation on the quality of life and markers of stress in persons living with HIV who also use crack cocaine
Q41643193Discontinuation of tenofovir disoproxil fumarate for presumed renal adverse events in treatment-naïve HIV-1 patients: meta-analysis of randomized clinical studies
Q56911620Expert consensus statement on the science of HIV in the context of criminal law
Q33891075Practicalities and challenges in re-orienting the health system in Zambia for treating chronic conditions
Q40060299Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach
Q90360776Strengths and Limitations of the Veterans Aging Cohort Study Index as a Measure of Physiologic Frailty
Q38714925Tat-Mediated Induction of miRs-34a & -138 Promotes Astrocytic Activation via Downregulation of SIRT1: Implications for Aging in HAND.

Search more.